Samsara Vision, Inc.

  • Home
  • Company
    • Overview
    • Executive Team
    • Board of Directors
    • For Investors
    • Career Opportunities
  • Implantable Telescope Technology
    • Overview
    • New Technology
    • Ultra-Precision Micro-Optics
    • Scientific Publications
  • AMD
  • Patients & Caregivers
    • Overview
    • Patient Journey
    • Patient Expectations
    • Clinical Trial Outcomes
    • Vision & AMD Patient Resources
    • Important Safety Information
  • Healthcare Providers
    • Technology
    • Clinical Safety and Efficacy Data
    • Reimbursement
  • Press Releases
  • Contact

Press Releases

Jul 06, 2020 8:00am EDT

Samsara Vision Names Thomas Ruggia as New Chief Executive Officer

May 13, 2020 8:00am EDT

Samsara Vision Announces CE Mark Approval of the Tsert-SI™ Delivery System for the CentraSight Treatment Program

Mar 26, 2019 8:00am EDT

Samsara Vision Announces Regulatory Approval of the CentraSight Treatment Program in Australia

Nov 28, 2018 8:00am EST

Loma Linda Patient First in California to Receive a Telescope Implant for Macular Degeneration after Having Cataract Surgery

May 14, 2018 8:00am EDT

Telescope Implant for End-Stage Macular Degeneration Now on the Federal Supply Schedule and Available at Department of Veteran’s Affairs Hospitals Across the Country

Sep 15, 2017 8:00am EDT

First Patient in the Nation Receives a Telescope Implant for Age-Related Macular Degeneration after Previous Cataract Surgery

Apr 04, 2017 8:00am EDT

CentraSight® Announces Partnership with BrightFocus® Foundation to Further AMD Research and Patient Education

Jan 10, 2017 8:00am EST

FDA Grants Samsara Vision Approval to Initiate Clinical Study of the Telescope Implant in Post-Cataract Patients

Mar 10, 2016 8:00am EST

VisionCare Ophthalmic Technologies Announces Appointment of Industry Veteran, Thierry Clidiere, to its Board of Directors

Feb 18, 2016 8:00am EST

Nearly 3 out of 4 Americans Don’t Know the Leading Cause of Blindness in People Over Age 60

  • Previous
  • 1
  • 2
  • 3
  • Next
RSS
© 2023 Samsara Vision, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap

The Implantable Miniature Telescope is referred to as "the IMT (by Dr. Isaac Lipshitz)" or as "the Implantable Miniature Telescope (by Dr. Isaac Lipshitz)." Hereinafter, this device may be referred to as "the product", "the device", "the telescope", "intraocular telescope", or similar terms which cannot be read as the name of the product. Restricted device: U.S. Federal Law restricts this device to sale, distribution, and use by or on the order of a physician or other licensed practitioner. ©2018 Samsara Vision, Inc. All rights reserved.